Colin Dormuth

Colin Dormuth

Colin Dormuth

Associate Professor

Faculty Bio

Dr. Colin Dormuth is an Associate Professor in the Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia. He is also Co-Managing Director of the Therapeutics Initiative (TI), and the British Columbia Lead for the Canadian Network for Observations Drug and Effectiveness Studies (CNODES). His research focuses on drug safety and effectiveness, as well as the design and evaluation of reimbursement policies for prescription drugs. He has training in economic theory, applied econometrics, epidemiology, health services outcome research, and biostatistics. Dr. Dormuth holds a Sc.D. and S.M. in epidemiology from Harvard University, an M.A. in economics from the University of Victoria, and a B.A. in economics from the University of Manitoba.

Social Media / Lab or Research Website

Website: https://ti.ubc.ca/


Research Interests

Preventive drugs for chronic diseases; expensive drugs for rare diseases; likelihood-based methods of inference

Research Theme(s)

Evidence-based medicine and knowledge translation, Pharmacoepidemiology

Publication Link(s)

0RCID: 0000-0001-8577-8783


Clinical Interests


Services


Teaching

PCTH_V 512


Wade Thompson

Wade Thompson

Assistant Professor

Faculty Bio

Wade Thompson received his BSc Phm (2013) and PharmD (2017) from University of Waterloo. He has practiced as a clinical pharmacist in long-term care, interdisciplinary primary care clinics (Family Health Teams), and geriatric outpatient clinics. In Wade’s clinical work, he routinely encounters older persons taking many medications, some of which are unnecessary or even causing harm. His clinical and research work aims to address this issue and ensure that older persons are only taking medications that are necessary, effective, safe, and consistent with their healthcare goals and treatment preferences. This often means stopping medications when they are no longer a good fit (termed “deprescribing”). Wade’s research program focuses on developing and evaluating different strategies for deprescribing in clinical practice. This involves knowledge synthesis and knowledge translation, as well as implementation science approaches to deprescribing. He has particular interest in shared decision-making and communication around deprescribing, and strategies that incorporate patient values and preferences into deprescribing decisions. Wade employs various methods in his research including qualitative research, surveys, systematic reviews, guideline development, and clinical trials. He is an co-lead of deprescribing.org, an international leader in deprescribing. He is also an executive committee member of the Canadian Medication Appropriateness and Deprescribing Network, and a member of the Therapeutics Initiative. Wade maintains active collaborations with researchers in Denmark, Australia, United States, Ireland, and United Kingdom. Wade’s work had been published in leading medical and geriatrics journals including BMJ, JAMA Network Open, Age and Ageing, and Journal of the American Geriatrics Society. Wade completed an MSc in clinical epidemiology at the University of Ottawa (2017) working as part of the deprescribing.org team developing evidence-based guidelines, clinical decision support tools, and patient engagement materials related to deprescribing. He completed a PhD at the University of Southern Denmark (2021) where he was part of a team that examined use and deprescribing of preventive medications among frail older persons. He completed a postdoctoral fellowship at Women’s College Hospital and ICES in Toronto as part of a team studying an implementation science approach to optimizing cardiovascular care.

Social Media / Lab or Research Website

Website: https://deprescribing.org

Social Media:
https://x.com/deprescribing

https://x.com/wadddee

https://www.linkedin.com/in/wade-thompson-b453853b

https://scholar.google.ca/citations?user=aCJUE7oAAAAJ&hl=en


Research Interests

Knowledge synthesis and knowledge translation in deprescribing, Deprescribing guidelines, Implementation science and deprescribing, Pharmacoepidemiological studies on medication use in older persons

Research Theme(s)

Clinical Outcomes and Patient Safety, Evidence-based medicine and knowledge translation, Pharmacoepidemiology

Publication Link(s)

Google Scholar: https://scholar.google.ca/citations?user=aCJUE7oAAAAJ&hl=enQ20.


Clinical Interests

Deprescribing Polypharmacy management Care of older persons


Services

Co-Lead, Deprescribing.org; Member, Executive Committee of Canadian Medication Appropriateness and Deprescribing Network; Editorial boardmember, BMC Primary Care


Teaching

PCTH_V 400

PCTH_V 548F


Jennifer Shabbits

Jennifer Shabbits

Associate Professor of Teaching

Faculty Bio

Dr. Shabbits earned her BSc (2006) in Biochemistry at Simon Fraser University and her PhD (2003) in Pharmaceutical Sciences at UBC. She beganteaching undergraduate biology and pharmacy courses at UBC while still a graduate student herself, and enjoyed the experiences so much that shemade teaching her focused career. She joined the APT department in 2004 as a tenure-track instructor and was promoted to Senior Instructor withtenure in 2011, and subsequently to Associate Professor of Teaching in 2020. Dr. Shabbits teaches introductory pharmacology and health science topicsto 2nd and 3rd year undergraduate science students, 1st and 2nd year medical students and 1st year midwifery students. Her classes range from large(300+ student) lectures distributed across the province to small group case- based learning tutorials. Dr. Shabbits holds curriculum development andleadership roles in the MD Undergraduate Program and is the Year 1 Site Director for the Vancouver-Fraser medical cohort. She is the interim director ofthe MEDD 411 course in the medical program and the MIDW 125 course director in Department of Family Practice.

Social Media / Lab or Research Website

Website (or Lab): 



Clinical Interests


Services


Teaching

PCTH_V 201

PCTH_V 325 (Course Director 2005-2021)

MEDD_V 411 (Course Director 2024)

MEDD_V 412 (Week Lead)

MEDD_V 421

MIDW_V 125 (Course Director 2021 – Present)


Roanne Preston

Roanne Preston

Professor
BC Women’s Hospital

Faculty Bio

Obstetric Anesthesiologist providing clinical care at BC Women’s Hospital. Former UBC Department Head to 2023

Social Media / Lab or Research Website

Website (or Lab): 


Research Interests

The obstetric airway, Optimizing labour analgesia and postpartum analgesia, Gastric POCUS, Surgical outcomes.

Research Theme(s)

Acute and Chronic Pain Management, Clinical Outcomes and Patient Safety, Obstetric anesthesiology

Publication Link(s)

ORCID: 0000-0002-1285-7728


Clinical Interests

Obstetric Anesthesia, Perioperative Anesthesia


Services

C&W MAC Chair College of Physicians and Surgeons; NHMSF Program Committee Chair; UBC Department Head 2012-2023 Department Head; BC Women’s Hospital 2004-2012; Senior Medical Director BC Women’s Hospital 2008-2012; CJA Editorial Board member 9 years, currently; Peer Reviewer Royal College Examiner 2007-2012.


Teaching

PCTH_ 548A Co-director Lecturer

PCTH_V 400

MIDW_V 125

MEDD_V 299

Residency program lecturer: Anesthesiology, Family Practice Anesthesia

CME provider for numerous events


Catherine Pang

Portrait photo of Catherine Pang
Professor

Faculty Bio

Social Media / Lab or Research Website

Website (or Lab: 


Research Interests

Research Theme(s)

Publication Link(s)


Clinical Interests


Services


Teaching

PCTH_V 301

PCTH_V 303

PCTH_V 201


Ismail Laher

Ismail Laher

Professor

Faculty Bio

My undergraduate education was at the University of London, which was followed by graduate studies in the USA and Canada. I have published more than 290 peer reviewed journal articles and am the Editor of three reference works. I am a full professor at UBC in Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine. My research interests are in the understanding of small artery regulation in health and disease. Our recent work focused on arterial regulation in animal models of sleep apnea, spinal cord injury and type 2 diabetes. We are also examining renal dysfunction in our animal model of sleep apnea. The emphasis is to examine the role of oxidative stress in these disorders with further studies on the role of exercise or anti-oxidant treatment. Our laboratory has more than 25 years of experience performing assessments of blood vessels including those of the systemic, coronary, and cerebral regions of small laboratory animals. In order to complete these assessments, we use pressure and wire myography combined with molecular techniques. We have a keen interest in examining the role of the endothelium in regulating vascular tone.

Social Media / Lab or Research Website

Website (or Lab): 


Research Interests

Sleep apnea, Diabetes Exercise, Free radical biology

Research Theme(s)

Publication Link(s)

ORCID: 0000-0002-3917-4417

PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=laher+i

Google Scholar: https://scholar.google.ca/citations?user=mM32NvQAAAAJ&hl=en&oi=aoQ20


Clinical Interests


Services

Editorial Board for 15 journals


Teaching

Year 2 Site Lead VFMP

PCTH_V514 Co-Lead Course Director


Amrit Singh

Amrit Singh

Assistant Professor
St. Paul’s Hospital

Faculty Bio

Dr. Singh received his Honours BSc in Biology and Mathematics from McMaster University and PhD in Experimental Medicine from the University of British Columbia under the supervision of Dr. Scott Tebbutt. Dr. Singh then pursued a post-doctoral fellowship with the PROOF Centre of Excellence with Drs. Bruce McManus and Raymond Ng. Dr. Singh was a principal statistical analyst at Bayer Pharmaceuticals prior to starting his faculty appointment in 2022 in Heart and Lung Pharmacogenomics. Dr. Singh leads a computational biology lab focused on biomarker discovery and developing methods and tools for multiomics data integration and visualization. Dr. Singh’s research focuses on the identification of biomarkers for heart and lung disease such as asthma and heart failure using high throughput biological (“omics”) datasets. Dr. Singh developed DIABLO, an integrative multiomics classification method as part of the mixOmics data integration project (mixomics.org). Through active collaborations with clinicians and wet-bench scientists, Dr.

Singh’s research incorporates patient cohorts with model systems with single cell and spatial technologies dissecting molecular mechanisms of disease, for the eventual goal of drug repurposing.

Social Media / Lab or Research Website

Website: https://cbl-hli.med.ubc.ca/

Social Media: https://linkedin.com/in/amrit-singh


Research Interests

Multimodal Data Integration, Biomarkers, Digital Pathology, Heart and Lung disease, Single-cell and Spatial Multiomics data

Research Theme(s)

Cardiopulmonary Sciences and anesthesiology

Publication Link(s)


Clinical Interests


Services


Teaching

PCTH_V 400

PCTH_V 548F

MEDI_V 570

BIOF_V 520


Matthew Wiens

Matthew Wiens

Assistant Professor
BC Children’s Hospital

Faculty Bio

Social Media / Lab or Research Website

Website: https://www.bcchr.ca/mwiens

Social Media: https://twitter.com/matthew_wiens


Research Interests

Prediction modeling, Risk-differentiated care, Digital health, Sepsis, Global health

Research Theme(s)

Clinical Outcomes and Patient Safety, Evidence-based medicine and knowledge translation, Pharmacoepidemiology

Publication Link(s)

ORCID: 0000-0002-3287-5181

PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=wiens+MO&otool=icaubclib

Google Scholar:https://scholar.google.ca/citations?hl=en&user=XHN8VkQAAAAJ&inst=17001591832933267808


Clinical Interests


Services


Teaching


Catrina Loucks

Catrina Loucks

Assistant Professor
BC Children's Hospital Research Institute

Faculty Bio

Dr. Catrina Loucks is an Assistant Professor at the University of British Columbia (Departments of Pediatrics and Anesthesiology, Pharmacology &Therapeutics), an Investigator at the BC Children’s Hospital Research Institute and a Member of the Academy of Translational Medicine. She hasexperience uncovering genetic causes for rare disorders from her MSc work at the University of Calgary, under the supervision of Drs. Micheil Innes andJillian Parboosingh. She then sought to explore functional impacts of uncovered genetic mutations by pursuing a PhD under the supervision of Dr. MichelLeroux at Simon Fraser University, using the simple roundworm, Caenorhabditis elegans, as a model. As a postdoctoral fellow at the University of BritishColumbia, Catrina worked with Dr. Bruce Carleton and the Canadian Pharmacogenomics Network for Drug Safety to understand how genetic variationcontributes to variable responses to medication. Her current research program, the CFI-JELF funded Loucks Pain Management Pharmacogenomics Lab,is developing a pipeline from genetic discoveries to predictive genetic testing to help select the safest and most effective pain relievers for children.

Social Media / Lab or Research Website

Website: 

Social Media: https://www.bcchr.ca/cloucks


Research Interests

Pharmacogenomics, Pain and pain management, Precision medicine, Drug safety and effectiveness – Children

Research Theme(s)

Acute and Chronic Pain Management, Clinical Outcomes and Patient Safety, Equity in Medicine, Evidence-based medicine and knowledge translation, Neurosciences and anesthesiology, Pediatric anesthesiology

Publication Link(s)

ORCID: 0000-0003-1167-3721


Clinical Interests

The Loucks Pain Management Pharmacogenomics Lab partners with clinicians to advance the discovery, validation and implementation of geneticpredictors of individual pain/opioid responses.


Services

Member, Department of Anesthesiology, Pharmacology & Therapeutics Research Advisory Committee, University of British Columbia Expert PanelMember, Motile Ciliopathy Gene Curation Expert Panel, Clinical Genome Resource (ClinGen): https://www.clinicalgenome.org/affiliation/40102/


Teaching

PCTH_V 325

PCTH_V 404

PCTH_V 548F

WACH_V 501

PHAR_V 302

GSAT_V 502


Donald Griesdale

Donald Griesdale

Associate Professor
Vancouver General Hospital

Faculty Bio

Don is an anesthesiologist and intensive care physician at Vancouver General Hospital and Associate Professor in the Department of Anesthesiology,Pharmacology & Therapeutics at the University of British Columbia. Following his clinical training, he completed a Masters of Public Health inQuantitative Methods from the Harvard School of Public Health in 2008. His clinical and academics areas of interest include neurocritical care of patientswith traumatic brain injury and hypoxemic ischemic brain injury following cardiac arrest. He is an active member of the Canadian Critical Care TrialsGroup. Collaborating with Dr. Penny Brasher, he was the Principal Investigator on a 2023 /2024 Grant-in-Aid from the Heart and Stroke Foundation ofCanada that will investigate the effect of VV-ECMO on cerebral blood flow in patients with ARDS. He is currently the Assistant Director at the Centre forClinical Epidemiology & Evaluation at the Vancouver Coastal Health Research Institute.

Social Media / Lab or Research Website

Website (or Lab): 


Research Interests

Hypoxic-ischemic brain injury, critical care epidemiologic outcomes, neurocritical care

Research Theme(s)

Clinical Outcomes and Patient Safety, Intensive Care, Transplant and Transfusion Medicine, Neurosciences and anesthesiology

Publication Link(s)

ORCID: 0000-0001-5985-8624

PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Griesdale+D


Clinical Interests

I practice critical care at Vancouver General Hospital. My clinical and research interest span two major areas: neurocritical care and epidemiologic outcomes from critical illness.


Services

I’m currently the Assistant Director at the Centre for Clinical Epidemiology & Evaluation. I’ve previously served as the Associate Vice-President of Medicine, Quality and Safety at Vancouver Coastal Health.


Teaching

PCTH_V 201

PCTH_V 400

I’ve also taught a variety of medical undergraduate lectures. I also teach medical undergraduates and residents while on clinical service.